New tentative approval for Dr Reddys drug ticagrelor

Copyright © DrugPatentWatch. Originally published at

[![ticagrelor structure](](//
Ticagrelor is the generic ingredient in two branded drugs marketed by Astrazeneca Pharms, Amneal, Hisun Pharm Hangzhou, Sigmapharm Labs Llc, Sunshine, and Watson Labs Inc and, and is included in six NDAs. There are four patents protecting this compound.

Drug patent litigation for TICAGRELOR.

This ingredient has two hundred and one patent family members in forty-eight countries.

Three suppliers are listed for this compound. There are five tentative approvals for this compound.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact or visit

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top